Healthcare -
Biotechnology - NASDAQ - US
$ 7.49
-9.54 %
$ 847 M
Market Cap
-2.22
P/E
DYN - GROSS PROFIT
Gross Profit DYN - Dyne Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR